According to Elevance Health's latest financial reports the company's current EPS (TTM) is HK$199.99. In 2022 the company made an earnings per share (EPS) of HK$193.57 a decrease over its 2021 EPS that were of HK$194.68.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$201.50 | 4.1% |
2022 | HK$193.57 | -0.57% |
2021 | HK$194.68 | 37.72% |
2020 | HK$141.36 | -3.38% |
2019 | HK$146.31 | 29.32% |
2018 | HK$113.14 | -1.43% |
2017 | HK$114.78 | 57.14% |
2016 | HK$73.04 | -3.41% |
2015 | HK$75.62 | 3.73% |
2014 | HK$72.90 | 12.44% |
2013 | HK$64.83 | 0.4% |
2012 | HK$64.57 | 12.6% |
2011 | HK$57.35 | 3.95% |
2010 | HK$55.17 | -28.94% |
2009 | HK$77.65 | 108.41% |
2008 | HK$37.26 | -15.07% |
2007 | HK$43.87 | 14.4% |
2006 | HK$38.34 | 22.03% |
2005 | HK$31.42 | 54.79% |
2004 | HK$20.30 | -6.62% |
2003 | HK$21.74 | 22.05% |
2002 | HK$17.81 |